HKEX: 455
Notification Letter and Reply Form to Registered Shareholders
Earlier from Tianda Pharmaceuticals
- Interim Report 2026
- Tianda Pharma Announces 2022/23 Interim Results
- Tianda Pharmaceuticals Annual Results 2022
- Tianda Pharmaceuticals: Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout